Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Naomi Cahn, Professor of Law, University of Virginia

Supreme Court unanimously concludes that anti-abortion groups have no standing to challenge access to mifepristone – but the drug likely faces more court challenges

Activists on both sides of the abortion battle are gearing up for it to be a major issue in the 2024 election. Pacific Press/LightRocket via Getty Images

On June 13, 2024, the Supreme Court of the United States unanimously decided to uphold access to mifepristone, one of two pills used in medication abortion. Mifepristone has long been used safely and effectively in medication abortions around the world.

Shortly after the 2022 Dobbs decision that overturned 50 years of abortion rights, anti-abortion groups and doctors challenged the Food and Drug Administration’s 2000 approval of mifepristone and its loosened regulations on how mifepristone is prescribed, arguing that it could not be used safely.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.